EPL
NUVB icon

EDBI Pte Ltd’s Nuvation Bio NUVB Stock Holding History

EDBI Pte Ltd’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$3.38M Hold
1,270,504
– – 3.58% 7
2024
Q3 		$2.91M Hold
1,270,504
– – 3.93% 6
2024
Q2 		$3.71M Hold
1,270,504
– – 4.19% 7
2024
Q1 		$4.62M Hold
1,270,504
– – 5.2% 7
2023
Q4 		$1.92M Hold
1,270,504
– – 1.9% 9
2023
Q3 		$1.7M Hold
1,270,504
– – 1.84% 10
2023
Q2 		$2.29M Hold
1,270,504
– – 1.85% 10
2023
Q1 		$2.11M Hold
1,270,504
– – 2.36% 10
2022
Q4 		$2.44M Hold
1,270,504
– – 3.11% 10
2022
Q3 		$2.85M Hold
1,270,504
– – 3% 9
2022
Q2 		$4.12M Hold
1,270,504
– – 3.82% 10
2022
Q1 		$6.68M Hold
1,270,504
– – 4.45% 9
2021
Q4 		$10.8M Buy
+1,270,504
New +$11.7M 5.87% 8

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

EDBI Pte Ltd's NUVB Position: Q4 2024 in Review

EDBI Pte Ltd held its Nuvation Bio (NUVB) position steady in Q4 2024 at 1,270,504 shares worth $3.38M. The position accounts for 3.58% of the portfolio, ranked #7.

EDBI Pte Ltd first reported a position in NUVB in Q4 2021 and has held it in 13 quarters since. The position peaked at $10.8M in Q4 2021. 160 funds tracked by Wall St. Rank hold NUVB as of Q4 2024.

  • EDBI Pte Ltd held 1,270,504 shares of Nuvation Bio worth $3.38M as of Q4 2024.
  • EDBI Pte Ltd left its Nuvation Bio share count unchanged in Q4 2024.
  • Nuvation Bio made up 3.58% of EDBI Pte Ltd's portfolio in Q4 2024, its #7 holding.
  • EDBI Pte Ltd first reported a position in Nuvation Bio in Q4 2021 and has held it in 13 quarters since.
  • EDBI Pte Ltd's Nuvation Bio position peaked at $10.8M in Q4 2021.
  • 160 funds tracked by Wall St. Rank held Nuvation Bio as of Q4 2024.

Based on EDBI Pte Ltd's 13F filing for Q4 2024, filed 4 Feb 2025.